Form 4: Orthopediatrics Corp. Director Mark C. Throdahl Reports Acquisition of Shares
SEC Form 4 Filing
Director Mark C. Throdahl reports acquiring 21,623 shares of Orthopediatrics Corp. common stock on June 11, 2024.
Summary
- On June 11, 2024, Mark C. Throdahl, a director of Orthopediatrics Corp., acquired 21,623 shares of common stock.
- The acquisition was a direct transaction.
- Following the transaction, Throdahl directly owns 159,480 shares of common stock, which includes 44,252 restricted stock awards.
- Throdahl also indirectly owns 22,497 shares through a trust.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of share acquisition by a director. The acquisition itself could be interpreted as slightly positive, but the filing is purely informational.
Positives
- The director's acquisition of shares could be seen as a positive signal to the market.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company insiders, such as directors and officers, and their confidence in the company's prospects.
Stakeholder Impact
- The acquisition of shares by a director may increase investor confidence.
Key Dates
| Date | Description |
|---|---|
| 06/11/2024 | Date of transaction: Acquisition of 21,623 shares of common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.